Nightingale Health Oyj Management
Management criteria checks 4/4
Nightingale Health Oyj's CEO is Teemu Suna, appointed in Jan 2014, has a tenure of 10.67 years. total yearly compensation is €1.59M, comprised of 18.8% salary and 81.2% bonuses, including company stock and options. directly owns 4.42% of the company’s shares, worth $11.77M. The average tenure of the management team and the board of directors is 7.7 years and 6.7 years respectively.
Key information
Teemu Suna
Chief executive officer
€1.6m
Total compensation
| CEO salary percentage | 18.8% |
| CEO tenure | 10.7yrs |
| CEO ownership | 4.4% |
| Management average tenure | 7.7yrs |
| Board average tenure | 6.7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -€18m |
| Sep 30 2023 | n/a | n/a | -€18m |
| Jun 30 2023 | €2m | €299k | -€18m |
| Mar 31 2023 | n/a | n/a | -€18m |
| Dec 31 2022 | n/a | n/a | -€19m |
| Sep 30 2022 | n/a | n/a | -€17m |
| Jun 30 2022 | €2m | €290k | -€16m |
| Mar 31 2022 | n/a | n/a | -€14m |
| Dec 31 2021 | n/a | n/a | -€12m |
| Sep 30 2021 | n/a | n/a | -€11m |
| Jun 30 2021 | €776k | €287k | -€10m |
Compensation vs Market: Teemu's total compensation ($USD1.76M) is about average for companies of similar size in the US market ($USD1.46M).
Compensation vs Earnings: Teemu's compensation has been consistent with company performance over the past year.
CEO
Teemu Suna (42 yo)
10.7yrs
Tenure
€1,590,000
Compensation
Mr. Teemu Suna is Founder at Nightingale Health Ltd. and has been its Chief Executive Officer since 2014. He is also Director at Nightingale Health Ltd.since 2021. His main work experience: Fujitsu Servic...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 10.7yrs | €1.59m | 4.42% $ 11.8m | |
| Founder | 11.7yrs | €24.00k | 8.88% $ 23.6m | |
| Co-Founder & COO | 9.7yrs | no data | 1.03% $ 2.7m | |
| Founder & Scientific Director | no data | no data | 1.89% $ 5.0m | |
| Founder & Laboratory Director | no data | no data | 8.88% $ 23.6m | |
| Chief Financial Officer | 2.8yrs | no data | no data | |
| Chief Scientific Officer | 3yrs | no data | 0.014% $ 36.9k | |
| Chief Legal Officer | 7.7yrs | no data | 0.14% $ 365.1k | |
| Chief Research & Development Officer | 3.7yrs | no data | 0.12% $ 331.9k | |
| Director of Business Operations | no data | no data | no data |
7.7yrs
Average Tenure
43yo
Average Age
Experienced Management: NGHL.F's management team is seasoned and experienced (7.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 8.7yrs | €1.59m | 4.42% $ 11.8m | |
| Founder | 11.7yrs | €24.00k | 8.88% $ 23.6m | |
| Independent Director | 4.7yrs | €24.00k | 1.38% $ 3.7m | |
| Independent Chairman | 3.7yrs | €24.00k | 1.41% $ 3.7m | |
| Director | 1.4yrs | €4.00k | no data | |
| Independent Director | 9.7yrs | €24.00k | no data | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Members of the Scientific Advisory Board | no data | no data | no data | |
| Member of the Scientific Advisory Board | no data | no data | no data |
6.7yrs
Average Tenure
53yo
Average Age
Experienced Board: NGHL.F's board of directors are considered experienced (6.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/09/03 16:25 |
| End of Day Share Price | 2024/06/06 00:00 |
| Earnings | 2023/12/31 |
| Annual Earnings | 2023/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Nightingale Health Oyj is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Marianne Palmu | Inderes Oy |
| Antti Luiro | Inderes Oy |